Abstract
Precision (or personalized) medicine holds great promise in the treatment of breast cancer. The success of personalized medicine is contingent upon inclusivity and representation for minority groups in clinical trials. In this article, we focus on the roadblocks for the African American demographic, including the barriers to access and enrollment in breast oncology trials, the prevailing classification of race and ethnicity, and the need to refine monolithic categorization by employing genetic ancestry mapping tools for a more accurate determination of race or ethnicity.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 605-611 |
| Number of pages | 7 |
| Journal | Breast Cancer Research and Treatment |
| Volume | 187 |
| Issue number | 3 |
| DOIs | |
| State | Published - Jun 2021 |
Keywords
- African Americans
- Ancestry informative markers
- Oncology trials
- Race/ethnicity classification
ASJC Scopus subject areas
- Oncology
- Cancer Research
Fingerprint
Dive into the research topics of 'Undercutting efforts of precision medicine: roadblocks to minority representation in breast cancer clinical trials'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS